Last reviewed · How we verify
NCT04805684
Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia
NA trial testing LUS Twelve area in Lung Ultrasound in 59 participants. Completed in 5 March 2021.
5 March 2021
Quick facts
| Lead sponsor | Bursa Yuksek Ihtisas Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 59 |
| Start date | 1 January 2021 |
| Primary completion | 5 March 2021 |
| Estimated completion | 5 March 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- LUS Twelve area
- LUS Fourteen area
Conditions studied
- Lung Ultrasound — all drugs for Lung Ultrasound →
- Pneumonia — all drugs for Pneumonia →
- Covid19 — all drugs for Covid19 →
Sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Who can join
Adults 18 to 85, any sex, with Lung Ultrasound or Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04805684
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Ultrasound
Currently open trials in the same condition.
- NCT06921993 — Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia · NA · recruiting
- NCT05492344 — Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome · NA · recruiting
- NCT05035459 — B-lines-guided Heart Failure Management in Heart Failure Patients · active not recruiting
Other Bursa Yuksek Ihtisas Training and Research Hospital trials
Trials by the same sponsor.
- NCT07397663 — Ultrasound-Based Prediction of Hemodynamic Instability During CVVHDF Initiation · not yet recruiting
- NCT07346885 — Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery · NA · active not recruiting
- NCT07346872 — EXORA Block vs Epidural Analgesia in Gynecological Surgery · NA · active not recruiting
- NCT07314125 — ChatGPT-5 vs. CDSS for Drug-Drug Interactions in ICU · completed
- NCT07452367 — Optic Nerve Sheath Diameter and Cognitive Outcomes in Bentall Surgery · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04805684 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bursa Yuksek Ihtisas Training and Research Hospital
- Last refreshed: 18 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04805684.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing